Efficacy of Botulinum Toxin in Temporomandibular Disorders
Status:
Completed
Trial end date:
2021-07-30
Target enrollment:
Participant gender:
Summary
Temporomandibular disorders (TMDs) represent a multifactorial pathological group that gives
rise to a varied and complex symptomatology that includes decreased jaw movement, muscle and
joint pain, joint crepitation and limitation or functional deviation of the jaw opening.
All this is sometimes accompanied by headache and other painful symptoms in the neck
musculature, incapacitating for many patients and at considerable public health expense.
Intramuscular and intra-articular injections of botulinum toxin are a simple treatment that
has proven to be effective in the treatment of the painful symptoms of these disorders, being
a therapeutic option in situations of failure of conventional treatments, without presenting
adverse effects.
Our study presents the preliminary results of twenty patients treated with this therapy
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Salamanca
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A